Mylan Inventory Turnover Ratio 2006-2019 | MYL

Current and historical inventory turnover ratio for Mylan (MYL) from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Mylan inventory turnover ratio for the three months ending March 31, 2019 was 0.62.
Mylan Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.330B $11.434B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $53.484B 9.74
Bausch Health Cos (BHC) Canada $8.157B 5.57
Teva Pharmaceutical Industries (TEVA) Israel $8.044B 3.15
Dr Reddy's Laboratories (RDY) India $6.263B 23.43
ASPEN PHARMACR (APNHY) South Africa $3.213B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.677B 16.76
Amphastar Pharmaceuticals (AMPH) United States $0.912B 51.00
Homology Medicines (FIXX) United States $0.907B 0.00
Voyager Therapeutics (VYGR) United States $0.896B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.580B 0.87
Akorn (AKRX) United States $0.483B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.446B 0.00
CymaBay Therapeutics (CBAY) United States $0.427B 0.00
Assembly Biosciences (ASMB) United States $0.332B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.228B 0.00
Sol-Gel Technologies (SLGL) Israel $0.185B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.165B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.057B 0.00